Sign in
4

Changes in Ownership

Immunome Inc. Filed Acc 0001104659-21-043486

Options or other derivatives

  • Chief Development Officer acquired 125,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Giesing Dennis H · Chief Development Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-03-25 Grant or award : show line 1 in the form Stock Option (Right to Buy) +125,000 $31.83 2031-03-24 125,000 125,000 D
Loading xslF345X03/tm2111257-2_4seq1.xml…